首页> 外文期刊>Eye >Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery.
【24h】

Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery.

机译:先天性白内障手术后小梁切除术伴或不伴丝裂霉素C治疗无晶状体和假晶状体的小儿青光眼。

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose To evaluate the safety and efficacy of trabeculectomy with or without mitomycin-C (MMC) in the management of glaucoma in aphakia and pseudophakia following congenital cataract surgery.Patients and methods All patients of glaucoma with aphakia or pseudophakia who underwent trabeculectomy with or without MMC from January 1989 to April 2000 were included. The medical records of 19 consecutive patients (23 eyes) were reviewed. Data collected from a retrospective chart review were analysed. Outcome measures were evaluated using Kaplan-Meier survival analysis. Pre- and postoperative intraocular pressures (IOPs), visual acuities, success rate, bleb characteristics, surgical failure and complications were the main outcome measures. Successful IOP control was defined as an IOP between 6 and 21 mmHg, without antiglaucoma medications, without further antiglaucoma surgery and without any sight-threatening complication.Results The mean age of patients was 8.8+/-5.5 years at the time of trabeculectomy with MMC compared to 11.0+/-12.4 years for trabeculectomy without MMC. Eight patients underwent trabeculectomy with MMC and 11 patients underwent trabeculectomy without MMC. There was no statistically significant difference between the two groups in terms of visual acuity, IOP, antiglaucoma medications, age at cataract surgery and at trabeculectomy. The IOP reduced from a preoperative level of 34.2+/-8.9 mmHg (range: 20-52) to a postoperative level of 18.4+/-12.2 mmHg (range: 2-60) with a mean follow-up of 24.2+/-17.9 months. The mean reduction in IOP in the MMC group was 15.5+/-17.3 and 16.3+/-13.8 mmHg in the other group (P=0.967). Overall, complete success was achieved in 36.8%, qualified success in 21.1% and surgical failure in 42.1% of patients with a mean follow-up of 24.2+/-17.9 months. There was no difference in the success between the two groups at the last follow-up. One patient developed bleb-related endophthalmitis in both eyes following trabeculectomy with MMC.Conclusions The success rate of trabeculectomy in glaucoma following congenital cataract surgery was 36.8% at the end of 3 years. The present study proves a poor success rate of trabeculectomy in a small series of aphakic Asian Indian patients even with the use of MMC.Eye (2003) 17, 53-62. doi:10.1038/sj.eye.6700180
机译:目的评估先天性白内障手术后伴或不伴丝裂霉素-C(MMC)的小梁切除术在无晶状体和假晶状体青光眼处理中的安全性和有效性。从1989年1月到2000年4月。回顾了19例连续患者(23眼)的病历。分析从回顾性图表审查收集的数据。结果测量采用Kaplan-Meier生存分析进行评估。术前和术后眼压(IOP),视力,成功率,起泡特征,手术失败和并发症是主要的预后指标。成功的眼压控制被定义为6至21 mmHg的眼压,无需使用抗青光眼药物,无需进一步的抗青光眼手术,也没有任何威胁视力的并发症。结果MMC小梁切除术患者的平均年龄为8.8 +/- 5.5岁相比于无MMC的小梁切除术为11.0 +/- 12.4年。 8例行MMC小梁切除术,11例不行MMC小梁切除术。两组在视力,眼压,抗青光眼药物,白内障手术和小梁切除术的年龄方面无统计学差异。眼压从术前的34.2 +/- 8.9 mmHg(范围:20-52)降低到术后的18.4 +/- 12.2 mmHg(范围:2-60),平均随访24.2 +/- 17.9个月。 MMC组IOP的平均降低为15.5 +/- 17.3 mmHg,另一组为16.3 +/- 13.8 mmHg(P = 0.967)。总体而言,平均随访时间为24.2 +/- 17.9个月的患者中,完全成功率为36.8%,合格成功率为21.1%,手术失败率为42.1%。在最后一次随访中,两组的成功率没有差异。 1例患者行MMC小梁切除术后双眼均出现了与疱疹有关的眼内炎。结论3年末先天性白内障手术后青光眼小梁切除术的成功率为36.8%。本研究证明即使在使用MMC的少数亚洲无晶状体无眼患者中,小梁切除术的成功率也很低。Eye(2003)17,53-62。 doi:10.1038 / sj.eye.6700180

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号